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Abstract
It has been shown that molecular hydrogen (H2) acts as a therapeutic antioxidant and suppresses brain injury by buffering
the effects of oxidative stress. Chronic oxidative stress causes neurodegenerative diseases such as Parkinson’s disease (PD).
Here, we show that drinking H2-containing water significantly reduced the loss of dopaminergic neurons in PD model mice
using both acute and chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The concentration-
dependency of H2 showed that H2 as low as 0.08 ppm had almost the same effect as saturated H2 water (1.5 ppm). MPTP-
induced accumulation of cellular 8-oxoguanine (8-oxoG), a marker of DNA damage, and 4-hydroxynonenal (4-HNE), a
marker of lipid peroxidation were significantly decreased in the nigro-striatal dopaminergic pathway in mice drinking H2-
containing water, whereas production of superoxide (O2N
2) detected by intravascular injection of dihydroethidium (DHE)
was not reduced significantly. Our results indicated that low concentration of H2 in drinking water can reduce oxidative
stress in the brain. Thus, drinking H2-containing water may be useful in daily life to prevent or minimize the risk of life style-
related oxidative stress and neurodegeneration.
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Introduction
It has been reported that molecular hydrogen (H2) selectively
reduces the hydroxyl radical, the most cytotoxic of the reactive
oxygen species (ROS), and can thereby effectively protect cells.
Thus, inhalation of H2 gas strongly suppressed ischemic and
reperfusion brain injury [1,2] and consumption of water saturated
with H2 (H2 water) prevented stress-induced impairments in
learning tasks during chronic physical restraint [3] by buffering the
effects of oxidative stress or superoxide formation [4]. Oxidative
stress, linked to mitochondrial damage, is also a primary cause of
Parkinson’s disease (PD) [5–7]. PD is regarded as an intractable
neurodegenerative disease with pathological changes to dopami-
nergic neurons in the substantia nigra (SN) and nigro-striatal
dopaminergic nerve terminals, leading to movement disorders
such as tremor, rigidity and akinesia [8]. The 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP)-based PD model has been
important in elucidating the molecular cascade of cell death in
dopaminergic neurons as well as the discovery of PD genes [9].
MPTP itself is not toxic, and as a lipophilic compound can cross
the blood-brain barrier. Once inside the brain, MPTP is
metabolized into the toxic cation 1-methyl-4-phenylpyridinium
(MPP+) by the enzyme monoamine oxidase B (MAO-B) in glial
cells. MPTP has a quite selective ability to cause neuronal death in
dopaminergic cells, apparently through a high-affinity uptake
process, through a dopamine transporter (DAT) [10], after it has
been released from the glial cells. Inside dopaminergic neurons,
MPP+ interferes with complex I of the electron transport chain, a
component of mitochondrial metabolism, which leads to cell death
and causes the buildup of free radicals, toxic molecules that
contribute further to cell destruction [11].
Today, antioxidant compounds are widely recognized for the
potential therapeutic treatment of oxidative stress diseases. Some
antioxidant drugs and antioxidant materials in foods have been
tested in the MPTP mouse model [12,13]. Antioxidants not only
in foods but also in drinking water would offer a great advantage
over other forms of antioxidant therapy. In fact, it was reported
that drinking electrolyzed H2-saturated water showed an effect in
reduction of oxidative stress in rats, as measured by urine oxidized
guanine and hepatic lipid peroxide [14]. Recently it was also
shown that drinking H2-saturated water, instead of inhaling H2
gas, prevents cognitive impairment by reducing oxidative stress
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7247[3]. According to Nagata et al. [3], even in drinking water, H2 can
be delivered to the blood in minutes.
Using the widely accepted PD model, we have tested the effect of
H2-containing drinking water on the MPTP-induced loss of
dopaminergic neurons. Here we show that drinking H2 water
may potentially offer a great advantage over other forms of
antioxidanttherapy, particularlyforchronic pathological conditions
such as PD.
Results
Hydrogen water made by bubbling H2 gas and using
electrochemical reaction of magnesium
Hydrogen water (H2 water) could be made by several methods.
In the present experiments, H2 water made by two relatively easy
and safe ways was tested. The H2 content in H2 water, made by
either dissolving electrolyzed hydrogen into pure water (H2
bubbled water) or utilizing electrochemical reaction of magnesium
with water (H2/Mg water), declined with a half-time of ,2 h and
almost disappeared after 8 h (Figure 1). The time course of H2
content was similar in H2 bubbled water and H2/Mg water except
at 4 and 6 h, suggesting that H2 was better maintained in H2/Mg
water, though the mechanism was not clear.
The effect of H2 water on acute MPTP neurotoxicity
To simply observe the effect of H2 in drinking water, H2-bubbled
water was used for acute MPTP neurotoxicity tests. Mice were given
H2 water or non-H2 water for 7 days prior to the MPTP
administration and kept receiving it until the mice were killed and
brains were extirpated. Since the H2 content disappeared within 8 h
(Figure 1), water supply was restricted to 8 h per day so that most of
the water was taken by the mice during the first few hours of each
day. Systemic administration of MPTP caused a significant decrease
in the number of dopaminergic neurons in substantia nigra pars
compacta (SNpc) (38% of that after saline & non-H2 water)
compared to those in saline injection group, as shown by the
number of tyrosine hydroxylase (TH)-positive cells (Figure 2A).
Dopaminergic fibers in the substantia nigra pars reticulosa (SNpr)
werealsoapparentlyreduced.In micetreated with H2 water,the loss
of dopaminergic neurons in SNpc was about a half of that in mice
drinking non-H2 water (54% of saline & non-H2 water) and showed
a significant reduction in the loss of neurons in SNpc (Figure 2B). In
saline injected groups, there were no apparent effects of H2 on the
number of dopaminergic neurons in SNpc (Figure 2A, 2B). This
result was also supported by stereological analysis, a better method
for unbiased cell counting (Figure 2C, 2D). The number of TH-
positive neurons was significantly decreased by MPTP administra-
Figure 1. Time-dependent decrease of H2 content in each
drinking water and their pH. Hydrogen water was made by directly
bubbling H2 gas produced by electrolysis (H2 bubbled water) or
chemical reaction using Mg (Mg/H2 water). **P,0.01 compared to H2
bubbled water. Error bars represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g001
Figure 2. Drinking H2 bubbled water reduced loss of dopami-
nergic neurons in substantia nigra induced by acute injection
of MPTP. (A) Representative photomicrographs illustrating tyrosine
hydroxylase (TH)-staining in substantia nigra (SN) of indicated
treatment animal groups. TH-staining from mice with saline injection
drinking non-H2 water or H2-bubbled water and those from MPTP-
injected mice drinking non-H2 water or H2 bubbled water. Scale;
200 mm. (B) Average number of TH-positive neurons in SN pars
compacta (SNpc), measured in 20 mm coronal sections (n=4–6). (C)
Representative photomicrographs illustrating TH immunoreactivity in
the SN of indicated treatment animal groups. Staining is more intense
than in (A) because of increased section thickness (30 mm) required for
stereological analysis. Scale; 200 mm. (D) Quantification of TH-positive
neurons by stereology, as described in Materials and Methods. (n=4
each) (E) TH-positive neurons in SN from mice treated with 4 different
concentration of H2 (0.04, 0.08, 0.5, 1.5 ppm) in drinking water (n=4–6).
One-way ANOVA;
###P,0.001 compared to saline with non-H2 water;
*P,0.05, **P,0.01 compared to MPTP with non-H2 water. Error bars
represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g002
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103356491, saline & non-H2 water). However, drinking H2 water
significantly attenuated this decrease of neurons by MPTP without
any decrease in saline injected mice (71056325, MPTP & H2 water;
100946716, saline & H2 water). Morphological observations also
supported a lesser decrease of TH-immunoreactivity in both SNpc
and SNpr. This rigorous stereological analysis fully supports the
results obtained using conventional counting methods. Consequent-
ly, the protective effect of H2 was proved by two different counting
methods. The effects of H2 water were dose-dependent, with a
maximal effect at a much lower concentration (0.08 ppm) than
saturated concentration of H2 (1.5 ppm) (Figure 2E).
Mg/H2 water and its effect on acute MPTP model mice
For further experiments, H2/Mg water was used, which was
made by a much easier and safer procedure. H2/Mg water
contained about 0.08 ppm H2.H 2/Mg water showed a similar
protective effect as H2-bubbled water on the loss of dopaminergic
neurons in acute MPTP model mice. Without MPTP administra-
tion, H2/Mgwater had no effecton the number of TH-positive cells
(19568; non-H2/Mg water, 19464; H2/Mg water, Figure 3A, 3C).
To test whether or not drinking H2/Mg water was effective even
after suffering oxidative stress, we compared two different
procedures (Figure 3B); one was giving H2/Mg water 7 days prior
to the acute MPTP administration (Figure 3B; shown as i) and the
other giving H2/Mg water only after MPTP administration
(Figure 3B; shown as ii). The result showed that drinking H2/Mg
water reduced the loss of dopaminergic neurons even after MPTP
injection (Figure 3B, 3C; 16% & 17% recovery in drinking protocol
shown as A&B, respectively). This may imply that drinking H2
water might be effective even after the onset of oxidative stress-
induced PD.
Since H2/Mg water was alkaline (pH ,8.8, Figure 1), we tested
the effect of alkalinized water (up to pH 8.8) made by adding
Mg(OH)2 to pure water. We also tested the effect of Mg and other
metal elements, Al and Zn which might possibly exist in H2/Mg
water, by leaving the H2/Mg water for 24 h (degassed H2/Mg
water) so that all the H2 had gone. Neither of these solutions had
any protective effect against MPTP-derived neurotoxicity
(Figure 4A, 4B). Thus, the effect of the H2/Mg water was not
due to metal elements or to its alkalinity but to its content of H2.
MPTP is converted into MPP+ which is indispensable for
MPTP-derived neurotoxicity. We therefore measured the amount
of MPP+ in the striatum where it was incorporated by DAT. The
amount of MPP+ in the striatum was not significantly different in
animals drinking H2 water and non-H2 water (Figure 4C).
Therefore, the effect of H2 water against the loss of dopaminergic
Figure 3. Drinking H2/Mg water before and after acute
injection of MPTP reduced loss of dopaminergic neurons. (A)
TH-positive dopaminergic neurons in SN. Mice were treated with non-
H2 water or H2/Mg water before and after acute MPTP injection. Scale;
200 mm. (B) Schedule for drinking H2 water before (i) and after (ii) MPTP
injection. (C) Average number of TH-positive neurons in mice with
acute injection of saline or MPTP. One-way ANOVA;
###P,0.001
compared to saline with non-H2 water; *P,0.05, **P,0.01 compared to
MPTP with non-H2 water. Error bars represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g003
Figure 4. H2, but not Mg ion and alkalinity, protected the
neuronal damage from acute MPTP neurotoxicity. (A) TH-
positive neurons in SN in mice drinking pure water (non-H2 water),
Mg(OH)2 water or degassed H2/Mg water. Neither Mg(OH)2 water nor
degassed H2/Mg water had significant effect on MPTP neurotoxicity.
(B) Average number of TH-positive neurons in SNpc in mice drinking
non-H2 water, Mg(OH)2 water, and degassed H2/Mg water. (C) The
amount of MPP+ in striatum in mice drinking H2/Mg water (white) and
pure water (black) was not significantly different. MPP+ was measured
3 h after the last MPTP administration, when the concentration
of MPTP reached maximum. One-way ANOVA. Error bars represent
mean 6 SEM.
doi:10.1371/journal.pone.0007247.g004
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MPTP.
The effect of H2 water in chronic MPTP infusion model
Despite the lack of parkinsonian symptoms in the acute MPTP
model in rodents, probably due to the low level of MAO-B in the
rodent brain’s capillaries [15], behavioral impairment could be
observed in the chronic MPTP infusion model using an osmotic
minipump to deliver the MPTP for long period [16]. This could
provide a better model for human PD. In this experiment, mice
were supplied with H2 water or non-H2 water 7 days prior to the
pump implantation and the water supply continued until brain
extirpation 28 days later (Figure 5A). Chronic infusion of MPTP
induced a loss of TH-positive dopaminergic neuron in SNpc
(Figure 5B). In mice drinking H2 water, the loss of TH-positive
cells (76% of control: saline & non-H2 water) was less than that in
mice drinking non-H2 water (56% of control: saline & non-H2
water) (Figure 5C). For the behavioral test, the ambulation scores
in the open-field test were compared. Using the slightly modified
open-field test reported previously [16], the ambulation score was
expressed as percentage of that obtained in the first trial. Drinking
H2 water did not show any significant change in the ambulation
score in mice with saline infusion (6963% with non-H2 water and
7366% with H2 water, respectively). The ambulation score in
mice with chronic MPTP infusion with non-H2 water was
4064%, while in mice with H2 water was 5464% (Figure 5D).
Other behavioral tests, for example the rotarod test and tail
suspension test, were also examined but no significant effects were
observed following chronic MPTP infusion (data not shown).
Hydrogen water reduced 4-HNE production in SN
dopaminergic neuron
4-HNE is an aldehyde toxic end product of lipid peroxidation
and one of the markers of membrane lipid peroxidation induced
by cytotoxic radicals such as NOH [17]. Also, 4-HNE is reported to
mediate the induction of neuronal apoptosis in the presence of
oxidative stress [18]. In the acute MPTP model, protein level of
4-HNE in midbrain is increased [12,19]. In saline-injected mice,
4-HNE immunoreactive fluorescence in TH-positive neuron was
minimal (Figure 6A, 6B). In contrast, in MPTP-treated mice,
4-HNE fluorescence was increased significantly 24 h after the last
injection of MPTP.
In mice drinking hydrogen water, the baseline level of 4-HNE
fluorescence was unchanged, but the striking increase in fluo-
rescence following MPTP administration was virtually annulled, to
a level that was not significantly above baseline (Figure 6B).
Hydrogen water failed to reduce the production of
intracellular superoxide in SN dopaminergic neuron
Intracellular superoxide (O2N
2) was detected by administration
of O2N
2 indicator, dihydroethidium (DHE) [20]. When DHE is
oxidized by O2N
2, it binds to DNA and a bright red fluorescence is
observed within the cell body.
The DHE intensity in TH-positive cell was significantly
increased in the acute MPTP-treated mice compared to saline-
treated mice (Figure 6A, 6B). Mice drinking hydrogen water
appeared to show a slight decrease of DHE fluorescent intensity
compared to non-hydrogen water mice with MPTP-injection, but
this was not statistically significant (p=0.21). As for microglia,
which is one of the sources of superoxide release in SN, microglia
did not show their activation 24 h, but 48 h after MPTP
treatment. In mice drinking H2 water, the morphological change
of microglia was also observed 48 h, but not 24 h after MPTP
administration (Figure S1).
Accumulation of cellular 8-oxoguanine in striatum
MPTP-induced lossof dopaminergicneuronisassociatedwith the
accumulationof8-oxoguanine(8-oxoG)inthenigro-striatalpathway
[5]. 8-oxoG is the major form of guanine oxidized by NOH, and is
accumulated in both mitochondrial and nuclear DNA [21]. Hence,
8-oxoG is widely used as an index of DNA oxidative stress. The
distinction between 8-oxoG accumulation in mitochondrial and
nuclear DNA can be made using immunohistochemical techniques
[5,22]. In our study, we investigated the accumulation of
mitochondrial 8-oxoG in the striatum, where the dopaminergic
nerve terminals end. Mitochondrial 8-oxoG showed significant
accumulation inthe striatum24 h afteracute MPTP administration.
Figure 5. Drinking H2/Mg water attenuated neurotoxicity and
behavioral phenotype induced by chronic infusion of MPTP. (A)
Schedule for continuous infusion of MPTP and behavioral observation.
Mice started to drink non-H2 water or H2/Mg water 1 week before
infusion of minipump. The 1
st open-field test was performed in the
morning of pump infusion. The 2
nd test was performed 28 days after
pump infusion. (B) TH-staining from mice with saline-infusion drinking
non-H2 water (I) or H2/Mg water (II) and those from mice with MPTP-
infusion drinking non-H2 water (III) or H2/Mg water (IV). (C) Average
number of TH-positive neurons in mice with saline- or MPTP-infusion
(n=6). Brain samples were obtained from six 20 mm coronal SN sections.
(D) Suppression of open-field activity by chronic infusion of MPTP was
partiallyrecoveredbydrinkingH2/Mgwater.Relativeambulationscore at
the 2
nd measurement was expressed as percentage of the 1
st
measurement (n=6 for each group). One-way ANOVA;
###P,0.001
compared to saline with non-H2 water; *P,0.05, **P,0.01 compared to
MPTP with non-H2 water. Error bars represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g005
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different fromthecontrol (Figure 7A,7B). At24 h after acute MPTP
administration, microglia in the striatum were activated in mice
drinking both H2 and non-H2 water (data not shown), and similarly
in the SN 48 h after MPTP administration (Figure S1).
Discussion
This study shows that drinking water containing H2 (H2 water)
attenuated the acute neurotoxic effects of MPTP on dopaminergic
neurons. H2 water was also effective on the behavioral impairment
produced by chronic administration of MPTP, the major symptom
of Parkinson’s disease (PD). We found that low concentration of
H2 in drinking water, well below saturating concentrations,
showed neuroprotective effects against the MPTP-induced loss of
dopaminergic neurons and neuronal fibers in nigro-striatal
pathway, and that this could be seen even after the start of the
neurotoxic insult. H2 water also reduced the amount of ROS-
derived oxidative products such as 4-HNE and 8-oxoG, which
would be primary causes of neuronal apoptosis in dopaminergic
neurons. Thus, our study may pave the way toward a new
neuroprotective strategy using H2 water in PD patients.
PD is a progressive, degenerative disorder of the nervous
system, meaning that it becomes increasingly disabling over time.
It is a chronic, life-long condition. Various causes have been
speculated: dopaminergic neurons can die or become damaged by
infection, trauma, or toxins found in the environment, like MPTP.
There may be also some genetic links. The impairments by all of
these causes are generally related to varying degrees of oxidative
stress [23]. Oxidative stress contributes to the cascade leading to
dopamine cell degeneration in PD. Studies revealed that several
biomarkers of oxidative damage are elevated in SN of PD brain
[9]. Also, dopaminergic neurons may be a particularly fertile
environment for the generation of ROS, as the metabolism of
dopamine produces hydrogen peroxide and superoxide radicals,
and auto-oxidation of dopamine produces dopamine-quinone, a
molecule that damages proteins by reacting with cysteine residues
[9,24].
Taking these reports into consideration, reducing oxidative
stress or oxidative damage would become a potential way to
prevent PD. H2 acts as a therapeutic antioxidant by selectively
reducing cytotoxic oxygen radicals [1–4,14,25,26], either by
inhalation or consumption. Although inhalation of H2 may act
Figure 7. H2 water decreased the accumulation of 8-oxoG in
striatum after MPTP administration. (A) Acute administration of
MPTP significantly increased the accumulation of mitochondrial 8-oxoG
(I and III) and induced the loss of TH-positive neurons and fibers (V and
VII). However, in mice drinking H2/Mg water, no significant 8-oxoG
accumulation (II and VI) nor TH-positive staining (VI and VIII) was
observed. Brains were extirpated 24 h after administration of saline or
MPTP. Scale: 500 mm. (B) Immunoreactive index for 8-oxoG and TH
(n=4 each). One-way ANOVA;
##P,0.01 and
###P,0.001 compared
to saline with non-H2 water; ***P,0.001, compared to MPTP with non-
H2 water. Error bars represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g007
Figure 6. H2 water reduced 4-HNE, but not DHE fluorescence in
SN after MPTP administration. (A) Fluorescent images of 4-HNE,
DHE, and TH in SN (n=3,4). Mice treated with non-H2 water or H2/Mg
water with injection of saline or MPTP. All samples were acquired 24 h
after administration of saline or MPTP. Scale: 50 mm. (B, C) Quantifica-
tion of 4-HNE (B) and DHE (C) intensity in TH-positive cells in SN. One-
way ANOVA;
#P,0.05,
###P,0.001 compared to saline with non-H2
water;
***P,0.001 compared to MPTP with non-H2 water. Error bars
represent mean 6 SEM.
doi:10.1371/journal.pone.0007247.g006
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continuous consumption. H2 water is clearly more convenient, and
fits well within a normal life-style. The most convenient form of H2
water is H2/Mg water. In our experiments, neither the alkalinity
nor the magnesium had any effect but the small amounts of
dissolved H2 turned out to have significant neuroprotective and
anti-oxidant effects.
As for the concentration of H2, it was reported that H2 dissolved
in arterial blood was increased by the inhalation of H2 in proportion
to the concentration inhaled, from 0 to 4%, together with O2 and
N2O; the amount of H2 dissolved in venous blood was less than that
in artery blood, suggesting that H2 had been incorporated into
tissues [1]. Recently it was also reported that the blood
concentration of H2 which was incorporated from the stomach
using water with saturated H2 was 5 mM [3]. We tried to measure
the concentration of H2 in rat striatum with cyclic voltammetry
analysis using a H2 electrode (Teflon-coated platinum electrode for
the cerebral blood flow study, 200 mm in diameter) [27] inserted
through a previously-mounted guide-cannula [28] (See Materials
and Methods S2). We could detect the change in H2 in the striatum
during the inhalation of H2 (Figure S2). It increased immediately
when the rats started to inhale the H2 gas and reached a plateau
within 10 minutes (0.22 ppm; 110 mM), but decreased soon after
stopping inhalation (t1/2=343 s; n=3). However, we could not
detect any change in H2 concentration on instilling saturated H2
water into the stomach in anesthetized rats or in free-moving rats
drinking H2-water. If there is 160 fold decrease in H2 concentration
between stomach and blood [3], there would be an even greater
decrease between the H2 concentration in drinking water
(maximum 1.5 ppm) and that in striatal tissue. This suggests that
the tissue H2 concentration would be below detection level.
Therefore, even though tissue H2 would be expected to rise after
drinking H2 water, currently there is a technical problem in
detecting such low levels.
In the PD model, ROS can be released from both cytosol and
mitochondria of DA neuron [29–32]. Administration of MPTP
causes its dysfunction via inhibition of complex I, which is
associated with the electron transport chain [11]. Subsequent
studies have identified abnormalities in complex I activity in PD
[9,33]. Mitochondrial dysfunction causes massive production of
ROS, especially O2N
2. At the nerve terminal of dopaminergic
neuron in the striatum, where there are abundant mitochondria,
more production of O2N
2 is predicted [9]. Furthermore, O2N
2
transforms into NOH by several steps including the Fenton
reaction, which is catalyzed by ferrous iron (Fe
2+). Fe
2+ can react
with hydrogen peroxide (H2O2) (produced during oxidative
deamination of dopamine) to generate NOH that can damage
proteins, nucleic acids, and membrane phospholipids, leading to
cellular degeneration [34–36]. We showed that a significant
increase in markers characteristic of oxidative damage in the
nigro-striatal pathway, such as 4-HNE, mitochondrial 8-oxoG,
and DHE, occurred 24 h after MPTP administration. 4-HNE and
8-oxoG are well-known markers for oxidative insult mainly caused
by NOH. 4-HNE was observed in membrane surface of TH-
positive dopaminergic neuron in SN, and mitochondrial 8-oxoG
was accumulated in the striatum over the same period (24 h after
MPTP administration). It has been previously reported that
mitochondrial 8-oxoG, the NOH -oxidative form of guanine and a
marker of DNA damage, is accumulated the striatum of MPTP-
injected mice [5]. However, hydrogen water significantly de-
creased the amount of 4-HNE in the SN and mitochondrial
8-oxoG in the striatum. This indicates that hydrogen acted by
reducing the primary production of NOH in the nigro-striatal
pathway.
A DHE fluorescence signal is detected when DHE and O2N
2
react and the oxidized DHE is incorporated into DNA. So, DHE
is widely used for imaging intracellular O2N
2 both in vitro and in vivo
[37–39]. During MPTP neurotoxicity, O2N
2 is released from not
only neuronal mitochondria, but also by auto-oxidation of
dopamine in dopaminergic neuron [40]. Also, NADPH oxidase
in activated microglia is a source of O2N
2 in the nigro-striatal
pathway [41]. However, in our experiments, we observed the
production of O2N
2 at 24 h, before microglial activation. Although
microglia are key players in the release of O2N
2, microglial
NADPH activity is enhanced together with microglial activation
and the peak of NADPH activity is only observed 48 h after
administration of MPTP [42]. In our case, microglia was activated
following the degeneration of dopaminergic neurons, not before,
as shown in Figure S1. Although some microglia in the SN were
activated in 24 h, we can conclude that DHE signals which we
observed in 24 h after MPTP injection mostly reflected neuronal
O2N
2 production in SN.
In a previous study, hydrogen reduced NOH but not other kinds
of reactive oxygen/nitrogen species [1]. However, in vivo, there is
little knowledge whether hydrogen shows selective reduction of
ROS [4]. In our experiment, DHE intensity was not significantly
reduced by hydrogen water in MPTP-treated mice, indicating that
hydrogen water showed less or no reduction of O2N
2. This accords
with the previous report that hydrogen showed a selective
reduction of ROS [1]. On the othet hand, another study has
shown that hydrogen water can reduce the amount of O2N
2 in vivo
[4]. These opposite results may relate to the different concentra-
tions of hydrogen in drinking water. Our hydrogen water
contained a much lower amount of hydrogen than saturated
hydrogen water, which may not be enough to reduce O2N
2.
We provided chronic MPTP administration model using
osmotic minipump modifying the previous method. However,
the number of TH-positive neurons in chronic MPTP model mice
was more than acute MPTP model mice. Continuous MPTP
infusion model caused less acute toxicity because the peak
concentrations of MPP+ in striatum were lower [16]. Several
reports indicated that the loss of dendritic processes in striatum
and nigral TH-positive neurons’ cell bodies were not permanent
and recovery of striatal and nigral TH-immunoreactivity were
observed after MPTP is eliminated systemically [42–44]. Such
increases in TH-immunoreactivity may reflect sprouting of
residual fibers [44] or the de novo appearance of TH-positive
neurons in dopamine-depleted striatum [45–47], but more likely
represent a compensatory mechanism for chronically reduced
dopamine levels as suggested from post-mortem studies of PD
brains [48]. Taking into consideration of these reports, we may
conclude that the number of TH-positive neurons in chronic
MPTP model does not decrease as much as in acute MPTP model
because chronic recovery and damage of TH fiber occurred
simultaneously in nigro-striatal pathway. Nevertheless, chronic
administration induced behavioral impairment. This impairment
may be due to degeneration of dopaminergic and noradrenergic
neurons, i.e. loss of dopamine and norepinephrine, but not
serotonin, from the target areas of the respective neurons. And
what is more, chronic neurotoxicity induced formation of neuronal
inclusion bodies and degeneration of catecholaminergic neurons,
similar to the effects of chronic administration of rotenone which is
also a mitochondrial complex I inhibitor [49–51]. Therefore,
continuous mitochondrial inhibition may impair the ubiquitin
proteasome system, which in turn recreates a disease state that
mimics human PD better than acute mitochondrial inhibition.
Dopaminergic lesions induced by MPTP are commonly used to
model of PD, and although MPTP effectively mimics the dopami-
Hydrogen in MPTP Model of PD
PLoS ONE | www.plosone.org 6 September 2009 | Volume 4 | Issue 9 | e7247nergic neuropathology of PD in mice, it fails to produce PD-like
motor deficits [52]. Although continuous MPTP administration with
an osmotic minipump mimics many features of the human disease
[16], no significant effects in behavioral impairment except only open-
field test showed significant change but not in other test such as
rotarod test, tail suspension test, and ring test (data not shown). In
acute PD model mice, age-related severity of dopaminergic
neurodegeneration and motor dysfunction to MPTP neurotoxicity
was reported. Although young (10 weeks) mice showed no mortality in
either MPTP treatment, older (14–15 months) mice exhibited
mortality from only two injections of MPTP during the experimental
period [53]. Though the effects of H2 water on behavioral response
were not tested in older mice in the current study, our results raised a
possibility that H2 water may reduce the movement disorder in PD
patients.
H2 would be also useful for other diseases which are caused by
oxidative stress. Already, H2 has been found effective for not only
ischemic injury but also hepatic damage and cognitive disease [1–
3,23]. On the other hands, 8-oxoG is accumulated both in nuclear
and mitochondrial genomes during aging [54], and dramatic
increase in 8-oxoG accumulation was reported in patients with
tumors [55] and other kinds of neurodegenerative disease such as
PD [56], Alzheimer’s disease [57] and amyotrophic lateral
sclerosis [58]. Several experiments using genetic knockout mice
revealed that the correlation between 8-oxoG accumulation and
functional disorder of repair enzymes such as MTH1 [59],
MUTYH [60], and OGG1 [61], suggesting that H2 may also
suppress tumorigenesis.
H2 gas itself has a risk of flammability and explosion. However,
drinking H2 water would be much safer and easier, being more
practical. In addition, the required concentration of H2 in drinking
water is not necessarily high. Our study also revealed that drinking
H2 water even after acute MPTP administration was effective as
well. While there is no known way to prevent PD, the current
studies strongly suggest that drinking H2 water could reduce the
risk of life style-related oxidative stress and related neurodegen-
erative diseases.
Materials and Methods
Hydrogen-containing water and its H2 content
Hydrogen-containing water (H2 water) was made by two ways.
One way was by dissolving H2 gas, produced by electrolysis of
water (hand-made by Panasonic Electric Works Co., Ltd., Japan),
directly into pure water. Another way was utilizing electrochem-
ical reaction between magnesium and water (H2O): Mg+2H2OR
Mg
2++2OH
2+2H2. A magnesium stick composed of 90% Mg, 9%
alminium and 1% zinc (6 mm diameter, 10 cm length, Nakagawa
Metal, Japan) was surface-cleaned with 0.1 N acetic acid and
dipped into pure water for about 1 minute. The maximum H2
content with this method was about 0.08 ppm, measured with a
hydrogen electrode (DH-35A, TOA DKK Co. Ltd., Japan).
Electrolyzed H2 water was also adjusted to have 0.08 ppm H2
unless otherwise indicated.
pH of H2 water and Mg(OH)2 solution
The pH of H2 water made by the chemical reaction with Mg
was about 8.8 due to the formation of Mg(OH)2, while the pH of
pure water was 5.9. To investigate the effect of the alkaline
solution (pH 8.8), Mg(OH)2 (,80 mM) was added to pure water.
Treatment of mice with H2 water
Animal protocols were approved by the Animal Care and Use
Committee of Kyushu University. Male C57BL/6J (CLEA Japan
Inc., Japan) mice of 8,12 weeks old were maintained on a 12:12 h
light/dark cycle. H2 water was made freshly each day and 40 ml
was delivered in glass bottles with tight rubber caps per 4 mice for
8 h (4–12 p.m.). Unless otherwise indicated, mice were treated
with H2 or non-H2 water for 7 days prior to MPTP adminis-
tration. For MPTP chronic model, treatment with H2 or non-H2
water continued after MPTP administration.
Acute injection and continuous infusion of MPTP
For acute injection of MPTP, MPTP-HCl (20 mg/kg free base,
SIGMA, USA) was administrated to mice intraperitoneally (i.p.)
three times (2 h apart) and brains were extirpated under anesthesia
48 h after the last MPTP injection. MPTP was dissolved in 0.9%
NaCl. For the continuous infusion of MPTP, an osmotic
minipump (ALZET model 2004, USA) was transplanted subcu-
taneously, releasing either saline solution or MPTP solution at
45 mg/kg daily. After implantation, the incision was sutured, and
disinfected with 70% ethanol every day. Twenty-eight days after
the start of MPTP infusions, brains were extirpated under
anesthesia. We checked that no solution was retained in the
pump after the brain was removed.
Immunohistochemistry of tyrosine hydroxylase (TH)
TH-positive neurons were stained as described previously [5].
Brain sections (20 and 40 mm thick in SN and striatum,
respectively) were incubated in blocking solution (Block Ace,
Dainippon Pharmaceutical, Japan) for 30 min at room tempera-
ture, and then incubated with primary antibody (rabbit anti-TH
antibody; 1:500, AB152, Chemicon, USA) in 10% Block Ace in
PBS, at 4uC overnight. The rinsed sections were immersed in a
solution of 3% H2O2 in methanol/PBS (1:1) for 30 min at room
temperature, and then processed by the Vectastain ABC kit
(Vector, USA) with secondary antibody (biotinylated anti-rabbit
IgG, 1:200, Vector, USA). The peroxidase reaction product was
detected using 3939-diaminobenzidine-tetrahydrochloride (DAB,
Vector, USA). All sections were then washed in PBS, cover-
slipped, and analyzed by AxioSkop2 equipped with with a CCD
camera, AxioCam (Carl Zeiss, Germany). The number of
dopamine neurons in the SNpc was estimated by counting all
TH-positive neurons of two hemispheres from six coronal sections
(20 mm thick) per animal that were distributed every 100 mm along
the rostral–caudate axis of the SN (23.08 to 23.64 mm caudal to
bregma) [62].
Microglial cells were stained as described in Materials and
Methods S1 [References S1].
Stereological analysis of nigral Dopaminergic neuron
We performed stereological analysis using slightly modified
method as described previously [63–65]. Coronal sections (30 mm
thickness) were obtained through SNpc (22.70 mm to 23.80 mm
relative to bregma) on MICROM cryostat. Free-floating sections
were incubated by Block Ace (Dainippon Pharmaceutics, Japan)
for 30 min followed by incubation of primary antibody (anti-TH
antibody, Chemicon, USA, 1:3000 in 10% Block Ace) for 2 days at
4uC. After the rinsed sections were immersed in a solution of 3%
H2O2 in methanol/PBS (1: 1) for 10 min at room temperature,
secondary antibody (biotinylated goat anti-rabbit IgG, 1:400,
Vector, USA) were incubated for 2 h, and then were processed by
Vectastain ABC kit (Vector, USA). The peroxidase reaction
product was detected using 3939-diaminobenzidinetetrahy-
drochloride (DAB, Vector, USA). All sections were coverslipped
with Glycergel Mounting Medium (Dako, Denmark).
For stereological counts, Stereo Investigator analysis software
(Stereo Investigator 8, MicroBrightField Inc., USA) was used to
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bodies in the SNpc using optical fractionator method [66]. The
boundary of SNpc was outlined under magnification of the 10x
objective. Every third section (eight sections per brain) were
obtained, and cells were counted with a 40x objective on a Nikon
ECLIPSE 80i using a grid of 70670 mm on a counting grid
(756100612 mm) with 2 mm upper and lower guard zones. The
absolute number of TH-positive neurons was directly calculated,
and the Gundersen’s coefficient of error in all samples were ,0.07.
Labeling of intracellular superoxide in vivo
Intracellular superoxide levels were detected by quantification
of fluorescence of the oxidation product of dihydroethidium
(DHE, Molecular Probes, USA). Oxidation of DHE by superoxide
converts DHE, which exhibits weak blue fluorescence, to an
ethidium derivative (oxy-Et) that exhibits peak fluorescence in the
rhodamine spectrum (excitation 480 nm, emission 567–586 nm)
[20]. DHE, which is cell permeant, enters the cell and, after
oxidation, binds to DNA with a small shift in its emission spectrum
to 567 nm. DHE has increased specificity for superoxide
compared with other dyes which are more general reactive
oxygen species probes. DHE solution (200 ml; 1 mg/ml in PBS)
was administrated intravenously 5 h before extirpating brain.
Brains were sliced into 40 mm thicknesses using a cryostat and
free-floating sections were obtained from the part of SN, as
mentioned above in TH immunohistochemistry.
For immunofluorescent staining of TH, sections were incubated
with Block Ace for 30 min at room temperature. The brain
sections were incubated overnight at 4uC with primary antibody,
rabbit anti-TH antibody (chemicon, 1:1000), and incubated for
4 h with Alexa fluor 488 goat anti-rabbit IgG (Molecular Probes,
1:500, USA) at room temperature. Every treatment was followed
by washing three times for 5 min with PBS. Sections were
mounted in the permafluor aqueous mounting medium (Thermo,
Japan) and were analyzed with a confocal laser scanning
microscope (LSM510META, Carl Zeiss, Germany).
Fluorescent labeling of 4-hydroxynonenal in SNpc
For detection of cellular lipid peroxide, we stained 4-hydroxyno-
nenal (4-HNE). Briefly, free-floating sections were obtained from the
part of SN, and incubated with primary antibody overnight following
to the incubation with Block Ace. Then, sections were incubated with
biotinylated anti-mouse IgG (Jackson, USA, 1:400), followed by
streptavidin Alexa 594 (Molecular Probes, USA, 1:1000). After
staining of 4-HNE, TH was stained as described above.
Quantitative analysis of DHE and 4-HNE fluorescent
signal
All samples were analyzed with a confocal laser scanning
microscope (LSM510META, Carl Zeiss, Germany). For each slice
10 series of z-stackimages correspondingto 2 mm on the z-axis were
obtained and projected using LSM image browser (Carl Zeiss,
Germany). For quantification of fluorescent intensity of DHE and
4-HNE, all images were converted to grayscale, and the average of
pixel intensity of each cell was measured using Adobe Photoshop
CS3 (Adobe Systems). Over 60 cells which were merged with TH
immunofluorescence were observed per animal and mean value of
intensity/cell/animal was calculated in each group.
Immunohistochemistry of 8-oxoguanine in striatum
The method of staining 8-oxoG in mitochondrial DNA was
described previously [5,22]. To eliminate cellular RNA, the
sections were incubated in 10 mM Tris-HCl (pH 7.5), 15 mM
NaCl containing DNase-free RNase (5 mg/ml of heat-incubated
RNase A, Sigma, USA) for 60 min at 37uC. In this condition,
nuclear DNA is not denatured at all, therefore the anti-8-oxoG
antibody cannot access to 8-oxoG residues buried in the intact
chromatin in nuclei, while the antibody easily accesses to 8-oxoG
residues in mitochondrial DNA which does not have a tight
chromatin structure. To detect 8-oxoG in nuclear DNA, section
has to be subjected to pre-treatment with 2N HCl for 1 h at room
temperature, which allows an efficient denaturation of nuclear
chromatin but an extensive degradation of mitochondrial DNA
[22]. Free-floating sections pre-treated were incubated in Block
Ace, for 30 min at room temperature, and then were incubated
with primary antibody (N45.1 mAb 1:100, Japan Institute for the
Control of Aging, Japan) in 10% Block Ace, at 4uC overnight. The
rinsed sections were immersed in a solution of 3% H2O2 in
methanol/PBS (1: 1) for 15 min at room temperature, and then
were processed by Vectastain ABC kit with a biotinylated
secondary antibody, and the peroxidase reaction product was
detected using DAB. Digital images were acquired using
Axioskop2 plus equipped with a CCD camera, AxioCam. All
sections from each experimental animal and group to be
compared were processed in parallel.
Quantitative morphometric analysis of 8-oxoG
All acquired digital images were processed uniformly, as
described previously [5], at a threshold in a gray scale mode to
subtract any background corresponding to the area without tissue,
and the optical density (OD) of each immunoreactive area was
calculated by Adobe Photoshop version 7.0 (Adobe Systems). From
each individual animal, five representative sections were measured
and the mean OD was calculated as an immunoreactivity index for
each animals. All quantitative analyses were performed by an
individual unaware of the experimental treatments.
Open-field test for continuous MPTP infusion model mice
Before and 28 days after osmotic pumps were implanted, open-
field tests were performed between 9 and 12 AM. A round open
field with 60 cm in base diameter and 90 cm in upper diameter,
surrounded by a 50 cm-high wall was used. During observation, a
100 W lamp-light was placed 80 cm above the field. Each mouse
was put at the center of the field and the movements were
recorded. Each mouse was tested for 3 min and the number of
times they crossed a line drawn in the field was counted (modified
from the method described previously [67]).
MPP+ measurement
HPLC-UV detection (wavelength, 295 nm) was used to
measure 1-methyl-4-phenylpyridinium (MPP+, SIGMA, USA)
levels in striatum using the method as described previously
[68,69]. Mouse brains were subjected to be measured 1.5, 3, 6 h
after MPTP was treated (n=4). The standard solution of MPP+
(500 nM) was made by dilution of MPP+ stock solution (1 mM in
20% glycerol, 2.5% MeOH in pure water, pH 4.0 with H3PO4).
Statistical Analysis
All data represent mean6standard error of means (SEM). The
data were compared with one-way ANOVA, followed by Bonferroni
test. Values of p ,0.05 were considered statistically significant.
Supporting Information
Figure S1 Immunohistochemistry of microglia in substantia nigra.
Mice drinking non-H2 water (H2(2)) or H2 water (H2(+))weretreated
with saline or MPTP. Brains were obtained 24 h or 48 h after the last
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with anti-Iba1 antibody (1:1000, WAKO). Scale: 50 mm.
Found at: doi:10.1371/journal.pone.0007247.s001 (3.97 MB TIF)
Figure S2 Representative concentration curve of H2 in striatum.
Anesthetized rats were inserted H2 electrode to right striatum and
currents were recorded by voltammetry. Rats started to inhale H2
gas at 200 s after the start of recording, and stopped at 800 s.
Found at: doi:10.1371/journal.pone.0007247.s002 (0.39 MB TIF)
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0007247.s003 (0.02 MB
DOC)
Materials and Methods S2
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